CenExel Clinical Research Acquires Rocky Mountain Movement Disorders Center

January 11, 2022

CenExel Clinical Research, Inc. acquired the clinical research site operations of Rocky Mountain Movement Disorders Center (now CenExel RMCR), expanding CenExel's neurology/CNS trial capabilities and site network. Objective, Investment Banking & Valuation acted as exclusive sell-side advisor to Rocky Mountain Movement Disorders Center and the transaction will allow the center to leverage CenExel's centralized processes and network.

Buyers
CenExel Clinical Research, Inc.
Targets
Rocky Mountain Movement Disorders Center (CenExel RMCR)
Sellers
Rocky Mountain Movement Disorders Center, Dr. Rajeev Kumar
Location
Colorado, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.